ScreenerHero

OPTH Optimi Health Corp.

NAS · US · Healthcare · Drug Manufacturers - Specialty & Generic · optimihealth.ca
4.040USD-2.18%Mkt Cap: 23.13M $P/E: —

Optimi Health Corp. operates as a pharmaceutical and nutraceutical drug manufacturing company in Canada. The company manufactures controlled substances including finished MDMA and psilocybin drug products, supplying them…

Industry Peers

Drug Manufacturers - Specialty & Generic
Screen all
MRK
Merck KGaA
$66.23BUSDP/E 25.7
TAK
Takeda Pharmaceutical Company Limited
$58.68BUSD
TEVA
Teva Pharmaceutical Industries Limited
$45.70BUSDP/E 65.3
GALD
Galderma Group AG
$43.27BUSDP/E 56.1
HLN
Haleon plc
$39.67BUSDP/E 18.4
SDZ
Sandoz Group AG
$34.93BUSDP/E 60.5
HLN
Haleon plc
$32.73BUSDP/E 19.0
ZTS
Zoetis Inc.
$29.57BUSDP/E 11.8
ZOE
Zoetis Inc.
$28.56BUSDP/E 12.2
UTHR
United Therapeutics Corporation
$23.38BUSDP/E 19.5
VTRS
Viatris Inc.
$20.09BUSD
SOBI
Swedish Orphan Biovitrum AB (publ)
$14.43BUSDP/E 112.9
NBIX
Neurocrine Biosciences, Inc.
$14.58BUSDP/E 21.0
IPN
Ipsen S.A.
$12.99BUSDP/E 23.5
ELAN
Elanco Animal Health Incorporated
$11.17BUSD
RDY
Dr. Reddy's Laboratories Limited
$10.22BUSDP/E 27.9
KRK
Krka, d. d.
$8.66BUSDP/E 19.3
ALKS
Alkermes plc
$6.95BUSDP/E 109.1
HIMS
Hims & Hers Health, Inc.
$6.89BUSD
AMRX
Amneal Pharmaceuticals, Inc.
$6.84BUSDP/E 40.1

Key Statistics

Company
Market Cap23.13M USD
Enterprise Value15.72M USD
Revenue (TTM)175.67K USD
Gross Profit-68.13K USD
Net Income (TTM)-3.71M USD
Revenue/Share0.05 USD
Last Price4.040 USD
Fiscal Year EndSep 2025
MR QuarterJun 2026
Employees—
CountryUS
SectorHealthcare
IndustryDrug Manufacturers - Specialty & Generic
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)—
PEG—
EV/EBITDA-3.74
EV/Revenue89.48
P/S134.61
P/B1.91
EPS (TTM)-1.56
EPS (Forward)—
52W Range
4.0002% of range6.400
52W High6.400 USD
52W Low4.000 USD
Profitability
Gross Margin-15.98%
Oper. Margin-957.82%
EBITDA Margin0.00%
Profit Margin-870.75%
ROE-56.49%
ROA-24.40%
Growth
Revenue Growth-28.60%
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.63M USD
CapEx (TTM)88.38K USD
FCF Margin-982.31%
FCF Yield-7.46%
Net Debt-7.93M USD
Net Debt/EBITDA1.88
Balance Sheet
Debt/Equity0.99
Current Ratio1.73
Quick Ratio1.62
Book Value/Sh2.16 USD
Cash/Share2.28 USD
Dividends
Fwd Div Rate—
Trail. Div Rate0.00 USD
Div. Yield0.00%
5Y Avg Yield—
Payout Ratio—
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.5.73M
Float4.65M
Insiders12.66%
Institutions7.75%
Short Interest
Short Ratio0.4d
Short % Out.0.36%
Shares Short20.50K
Short (prev mo.)17.68K
Technical
SMA 504.811 (-16.0%)
SMA 2004.846 (-16.6%)
Beta1.57
S&P 52W Chg15.78%
Avg Vol (30d)51.04K
Avg Vol (10d)29.14K
Technical Indicators
RSI (14)28.8
MACD-0.1456
MACD Signal-0.0569
MACD Hist.-0.0887
BB Upper5.286 USD
BB Middle4.699 USD
BB Lower4.111 USD
BB Width25.01%
ATR (14)0.2644 USD
Vol Ratio (20d)0.29x